Immutep Correlations
| PRRUF Stock | USD 0.20 0.00 0.00% |
The current 90-days correlation between Immutep Limited and Zura Bio Limited is -0.03 (i.e., Good diversification). The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Immutep Correlation With Market
Average diversification
The correlation between Immutep Limited and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Limited and DJI in the same portfolio, assuming nothing else is changed.
Immutep |
The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Limited to buy it.
Moving together with Immutep Pink Sheet
| 0.7 | NVO | Novo Nordisk AS | PairCorr |
| 0.69 | NONOF | Novo Nordisk AS | PairCorr |
| 0.77 | CSLLY | CSL | PairCorr |
| 0.77 | CMXHF | CSL Limited | PairCorr |
| 0.79 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.66 | MCAE | Mountain Crest Acqui | PairCorr |
| 0.8 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.82 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
| 0.75 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Immutep Pink Sheet
| 0.85 | AVTE | Aerovate Therapeutics | PairCorr |
| 0.77 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.73 | HNRC | Houston Natural Resources | PairCorr |
| 0.73 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
| 0.69 | SLF | Sun Life Financial | PairCorr |
| 0.77 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.74 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.72 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.72 | CSCO | Cisco Systems | PairCorr |
| 0.66 | DIS | Walt Disney Sell-off Trend | PairCorr |
| 0.65 | T | ATT Inc Sell-off Trend | PairCorr |
| 0.65 | WMT | Walmart | PairCorr |
| 0.63 | PYPL | PayPal Holdings Aggressive Push | PairCorr |
| 0.6 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.42 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.37 | HD | Home Depot | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Immutep Pink Sheet performing well and Immutep Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immutep's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ZURA | 3.96 | (0.53) | 0.00 | (0.11) | 0.00 | 7.95 | 26.70 | |||
| ENVB | 3.37 | (0.40) | 0.00 | 1.90 | 0.00 | 8.00 | 28.33 | |||
| EFTR | 7.57 | (4.40) | 0.00 | 3.06 | 0.00 | 8.70 | 88.91 | |||
| IMMX | 4.69 | 0.23 | 0.05 | 0.34 | 5.00 | 11.44 | 32.68 | |||
| ELEV | 3.64 | 0.21 | 0.05 | 0.26 | 4.39 | 8.33 | 22.21 | |||
| DSGN | 4.12 | 0.32 | 0.08 | 0.24 | 5.31 | 9.43 | 35.31 | |||
| ALXO | 3.82 | (0.43) | 0.00 | (0.28) | 0.00 | 9.30 | 26.52 | |||
| AADI | 2.04 | 0.31 | 0.12 | 0.37 | 2.25 | 5.08 | 13.95 | |||
| ADCT | 4.69 | 0.50 | 0.11 | 0.43 | 4.60 | 8.41 | 60.46 | |||
| ALVR | 3.78 | (0.48) | 0.00 | (0.17) | 0.00 | 6.25 | 47.97 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Immutep without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Immutep Corporate Management
| Frederic MD | Chief Officer | Profile | |
| Deanne LLB | Gen COO | Profile | |
| Indira Naidu | Joint Sec | Profile | |
| Shengfei Fang | F Sec | Profile | |
| Christian Mueller | Director Affairs | Profile |